Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: PHARMABLOCK(300725) the Revenue is 551.43 M (+18.66%);the EBIT is 50.48 M (+61.6%);the EPS is 0.22 (+22.26%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.55B18.66%
----
----
EBIT
0.05B61.60%
----
----
EPS
0.220122.26%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf